Risk factors | Overall n(%) | DM Complications | ||||||
---|---|---|---|---|---|---|---|---|
Macro-vascular Complications | Microvascular Complications | |||||||
CAD | Stroke | PAD | Retinopathy | Nephropathy | Neuropathy | Diabetic Foot | ||
HbA1c Categories | Â | Â | Â | Â | Â | Â | Â | |
 Control DM (HbA1c ≤ 7%) | 135(60.8) | 17(12.6) | 9(6.7) | 9(6.7) | 37(27.4) | 28(2.7) | 26(19.3) | 37(27.4) |
 Uncontrol DM (HbA1c > 7%) | 67(30.2) | 20(23.0) | 14(16.1) | 13(14.9) | 38(43.7) | 31(35.6) | 28(32.2) | 36(41.4) |
  p-value | 0.042 | 0.024 | 0.044 | 0.012 | 0.014 | 0.028 | 0.031 | |
Adherence to DM treatment | Â | Â | Â | Â | Â | Â | Â | |
 Yes | 92(41.1) | 6(6.5) | 3(1.9) | 4(4.3) | 13(14.1) | 7(6.5) | 9(9.8) | 23(25.0) |
 No | 130(58.6) | 31(23.8) | 20(15.4) | 18(13.8) | 62(47.7) | 52(45.6) | 45(34.6) | 50(38.5) |
  p-value | < 0.001 | 0.003 | 0.020 | < 0.001 | < 0.001 | < 0.001 | 0.035 | |
Family History of DM | Â | Â | Â | Â | Â | Â | Â | |
 Yes | 104(46.8) | 20(19.2) | 13(12.5) | 9(8.7) | 44(42.3) | 32(30.8) | 30(28.8) | 43(41.3) |
 No | 118(53.2) | 17(14.4) | 10(8.5) | 13(10.9) | 31(26.3) | 27(22.9) | 24(20.3) | 30(25.4) |
  p-value | 0.336 | 0.326 | 0.557 | 0.012 | 0.184 | 0.140 | 0.012 | |
BP Control | Â | Â | Â | Â | Â | Â | Â | |
 Yes | 133(53.2) | 16(12.0) | 6(4.5) | 4(3.0) | 38(28.6) | 29(21.8) | 34(25.6) | 53(39.8) |
 No | 89(40.1) | 21(23.6) | 17(19.1) | 18(20.2) | 28(41.6) | 30(33.7) | 20(22.5) | 20(22.5) |
  p-value | 0.023 | < 0.001 | < 0.001 | 0.045 | 0.049 | 0.599 | 0.007 | |
Type of DM | Â | Â | Â | Â | Â | Â | Â | |
 Type I | 81(36.5) | 24(29.6) | 16(19.8) | 15(18.5) | 33(40.7) | 27(33.3) | 28(34.6) | 43(53.1) |
 Type II | 141(63.5) | 13(9.2) | 7(5.0) | 7(5.0) | 42(29.8) | 32(22.7) | 26(18.4) | 30(21.3) |
  p-value | < 0.001 | < 0.001 | 0.001 | 0.097 | 0.084 | 0.007 | < 0.001 | |
Duration of DM (years) | Â | Â | Â | Â | Â | Â | Â | |
 < 10 | 72(32.4) | 6(8.3) | 3(4.2) | 3(4.2) | 27(37.5) | 16(22.2) | 15(20.8) | 20(27.8) |
 10–20 | 117(52.7) | 19(16.2) | 12(10.3) | 11(9.4) | 28(23.9) | 28(23.9) | 25(21.4) | 33(28.2) |
 > 20 | 33(14.9) | 12(36.4) | 8(24.2) | 8(24.2) | 20(60.6) | 15(45.5) | 14(42.4) | 20(60.6) |
  p-value | 0.002 | 0.007 | 0.006 | < 0.001 | .028 | 0.032 | 0.001 | |
Regular follow-up with physician | Â | Â | Â | Â | Â | Â | ||
 Yes | 126(56.8) | 13(10.3) | 6(4.8) | 5(4.0) | 21(16.7) | 19(15.1) | 17(13.5) | 29(23.0) |
 No | 93(43.2) | 24(25.0) | 17(17.7) | 17(17.7) | 54(56.3) | 40(41.7) | 37(38.5) | 44(45.8) |
  p-value | 0.004 | 0.002 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | 0.006 | |
Lipid Lowering Medication | Â | Â | Â | Â | Â | Â | ||
 Yes | 155(69.8) | 24(15.5) | 11(7.1) | 10(6.5) | 47(30.3) | 39(25.2) | 33(21.3) | 50(32.3) |
 No | 67(30.2) | 13(19.4) | 12(17.9) | 12(17.9) | 28(41.8) | 20(29.9) | 21(31.3) | 23(34.3) |
  p-value | 0.472 | 0.015 | 0.009 | 0.097 | 0.468 | 0.109 | 0.763 |